Robert D. Legare

A Tyrosine Kinase Created by Fusion of the <i>PDGFRA</i> and <i>FIP1L1</i> Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

Jan Cools, Daniel J. DeAngelo, Jason Gotlib et al. · New England Journal of Medicine · 2003 · 1.7K citations · Full text

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

Woo‐Joo Song, Melanie G. Sullivan, Robert D. Legare et al. · Nature Genetics · 1999 · 1.1K citations

Hematological Malignancy, Thrombosis, Acute Myelogenous Leukaemia +11

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease

Jan Cools, Elizabeth H. Stover, Christina Boulton et al. · Cancer Cell · 2003 · 216 citations · Full text

Hematological Malignancy, Murine Model, Immunology +8

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)

Nadine Tung, Banu Arun, Michele R. Hacker et al. · Journal of Clinical Oncology · 2020 · 125 citations · Full text

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals

T. Febbraro, Katina Robison, Jennifer Scalia Wilbur et al. · Gynecologic Oncology · 2015 · 116 citations · Full text

Family Medicine, Adherence Patterns, Cancer Epidemiology +9